{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:39:08Z","timestamp":1780483148064,"version":"3.54.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T00:00:00Z","timestamp":1442361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138250","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T16:09:25Z","timestamp":1442419765000},"page":"e0138250","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms"],"prefix":"10.1371","volume":"10","author":[{"given":"Haixiu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanggang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"EJ Baxter","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera","volume":"434","author":"C James","year":"2005","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/sj.leu.2404810","article-title":"Prevalence and clinicopathologic correlates of JAK2 exon12 mutations in JAK2V617F negative polycythemia vera","volume":"21","author":"A Pardanani","year":"2007","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"LM Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPLW515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients","volume":"108","author":"AD Pardanani","year":"2006","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Y Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"T Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative eoplasms with nonmutated JAK2","volume":"369","author":"J Nangalia","year":"2013","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1002\/cncr.24440","article-title":"The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos","volume":"115","author":"A Tefferi","year":"2009","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcmd.2011.04.004","article-title":"Detection of MPL exon10 mutations in 103 Chinese patients with JAK2V617F-negative myeloproliferative neoplasms","volume":"47","author":"X Chen","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3324\/haematol.2014.109249","article-title":"Calreticulin mutations in Chinese with primary myelofibrosis","volume":"99","author":"B Li","year":"2014","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/10428194.2014.939963","article-title":"CALR and ASXL1 mutation analysis in 190 patients with essential thrombocythemia","volume":"56","author":"H Shen","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.3324\/haematol.2014.109199","article-title":"Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients","volume":"99","author":"C Qiao","year":"2014","journal-title":"Haematologica"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s00277-014-2151-8","article-title":"Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia","volume":"93","author":"CC Chen","year":"2014","journal-title":"Ann Hematol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2014-05-578435","article-title":"Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis","volume":"124","author":"E Rumi","year":"2014","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood-2013-11-539098","article-title":"JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes","volume":"123","author":"E Rumi","year":"2014","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3324\/haematol.2014.107482","article-title":"Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations","volume":"99","author":"H Andrikovics","year":"2014","journal-title":"Haematologica"},{"key":"ref18","article-title":"Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1","author":"A Tefferi","year":"2010","journal-title":"Leukemia"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/gcc.21960","article-title":"Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms","volume":"51","author":"M Brecqueville","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood-2014-04-567024","article-title":"Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression inmyeloproliferative neoplasms","volume":"125","author":"E Chen","year":"2015","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13045-014-0048-6","article-title":"The Mutation Profile of JAK2 and CALR in Chinese Han Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms","volume":"7","author":"Z Wu","year":"2014","journal-title":"Journal of Hematology & Oncology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/leu.2014.270","article-title":"Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution","volume":"29","author":"X Cabagnols","year":"2015","journal-title":"Leukemia"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"C Lacout","year":"2006","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of JAK2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"G Wernig","year":"2006","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10428199609054858","article-title":"Leukocyte alkaline phosphatase a specific marker for the post-mitotic neutrophilic granulocyte: regulation in acute promyelocytic leukemia","volume":"23","author":"E Garattini","year":"1996","journal-title":"Leukaemia & Lymphoma"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2141.2010.08249.x","article-title":"JAK2V617F uses distinct signaling pathways to induce cell proliferation and neutrophil activation","volume":"150","author":"S Oku","year":"2010","journal-title":"British Journal of Haematology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/00313027409068999","article-title":"Leucocyte alkaline phosphatase in myeloid maturation","volume":"6","author":"CA Stewart","year":"1974","journal-title":"Pathology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2005-09-3826","article-title":"Relation between JAK2(V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders","volume":"107","author":"F Passamonti","year":"2006","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3324\/haematol.10991","article-title":"Accuracy of leukocyte alkaline phosphatase score to predict JAK2V617F mutation","volume":"92","author":"AL Basquiera","year":"2007","journal-title":"Haematologica"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0141173","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T00:00:00Z","timestamp":1444867200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T16:17:47Z","timestamp":1540225067000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138250"}},"subtitle":[],"editor":[{"given":"Connie J","family":"Eaves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,16]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138250","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0141173","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,16]]}}}